2023 - Research.com Microbiology in United States Leader Award
His primary scientific interests are in Escherichia coli, Microbiology, Virulence, Genotype and Enterobacteriaceae. Escherichia coli is a subfield of Genetics that James R. Johnson studies. His Microbiology study combines topics from a wide range of disciplines, such as Bacterial adhesin and Pulsed-field gel electrophoresis.
His biological study spans a wide range of topics, including Genotyping, Pathogen and Phylogenetics. The concepts of his Genotype study are interwoven with issues in Feces, Antibacterial agent and Cephalosporin. James R. Johnson usually deals with Enterobacteriaceae and limits it to topics linked to Pathogenicity island and Yersiniabactin.
James R. Johnson spends much of his time researching Microbiology, Escherichia coli, Virulence, Internal medicine and Antibiotic resistance. James R. Johnson has included themes like Genotype and Virology in his Microbiology study. James R. Johnson is exploring Escherichia coli as part of his Genetics and Gene and Escherichia coli studies.
His study looks at the relationship between Virulence and topics such as Phylogenetic tree, which overlap with Phylogenetics. His Internal medicine research includes themes of Gastroenterology, Surgery and Immunology. His Antibiotic resistance research is multidisciplinary, relying on both Multiple drug resistance and Antimicrobial.
James R. Johnson mainly focuses on Microbiology, Escherichia coli, Virulence, Antibiotic resistance and Internal medicine. His research integrates issues of Genotype and Sepsis in his study of Microbiology. His studies deal with areas such as Multiple drug resistance, Molecular epidemiology and Genome as well as Escherichia coli.
His Virulence study integrates concerns from other disciplines, such as Meningitis, Diarrhea and Colonization. His Antibiotic resistance research incorporates elements of Virology and Cephalosporin. His Internal medicine research includes elements of Gastroenterology and Antimicrobial.
James R. Johnson mostly deals with Microbiology, Escherichia coli, Antibiotic resistance, Virulence and Genetics. His Microbiology research incorporates themes from Sepsis, Genotype and Virology. Escherichia coli is the subject of his research, which falls under Gene.
His research in Antibiotic resistance intersects with topics in Bacteremia, Vancomycin, Fosfomycin and Intensive care medicine. James R. Johnson does research in Virulence, focusing on Extraintestinal Pathogenic Escherichia coli specifically. His Phylogenetics research focuses on subjects like Phylogenetic tree, which are linked to Yersiniabactin and Ecology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Social Phobia: Comorbidity and Morbidity in an Epidemiologic Sample
Franklin R. Schneier;Jim Johnson;Christopher D. Hornig;Michael R. Liebowitz.
Archives of General Psychiatry (1992)
Smoking, smoking cessation, and major depression.
Alexander H. Glassman;John E. Helzer;Lirio S. Covey;Linda B. Cottler.
JAMA (1990)
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
John W. Warren;Elias Abrutyn;J. Richard Hebel;James R. Johnson.
Clinical Infectious Diseases (1999)
Extended Virulence Genotypes of Escherichia coli Strains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise
James R. Johnson;Adam L. Stell.
The Journal of Infectious Diseases (2000)
The MEME Suite
Timothy L. Bailey;James Johnson;Charles E. Grant;William S. Noble.
Nucleic Acids Research (2015)
Virulence factors in Escherichia coli urinary tract infection.
James R. Johnson.
Clinical Microbiology Reviews (1991)
Organised Genome Dynamics in the Escherichia coli Species Results in Highly Diverse Adaptive Paths
Marie Touchon;Marie Touchon;Claire Hoede;Olivier Tenaillon;Valérie Barbe.
PLOS Genetics (2009)
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Marie Hélène Nicolas-Chanoine;Jorge Blanco;Véronique Leflon-Guibout;Raphael Demarty.
Journal of Antimicrobial Chemotherapy (2007)
Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem
Thomas A. Russo;James R. Johnson.
Microbes and Infection (2003)
Proposal for a New Inclusive Designation for Extraintestinal Pathogenic Isolates of Escherichia coli: ExPEC
Thomas A. Russo;James R. Johnson.
The Journal of Infectious Diseases (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Minnesota
University of Minnesota
VA Midwest Health Care Network
University of Minnesota
University of Pittsburgh
University of Minnesota
University of Washington
University at Buffalo, State University of New York
George Washington University
University of Adelaide
Gwangju Institute of Science and Technology
MIT
Centre national de la recherche scientifique, CNRS
University of Chicago
Institut de Ciència de Materials de Barcelona
Rice University
King's College London
Johns Hopkins University
Hannover Medical School
University of Naples Federico II
Monash University
Instituto Português do Mar e da Atmosfera
University of California, Irvine
University of Hong Kong
University of Waterloo